Literature DB >> 17823040

Detection of abdominal aortic graft infection: comparison of magnetic resonance imaging and indium-labeled white blood cell scanning.

Saeid Shahidi1, Anni Eskil, Erik Lundof, Anette Klaerke, Bent Skov Jensen.   

Abstract

Infected abdominal aortic grafts rank as one of the most severe complications of vascular surgery, with high mortality and morbidity. The incidence of infection after prosthetic aortic reconstruction is 1-3%. Diagnosis of vascular graft infection can be occasionally difficult. Clinical manifestations and assessment of the extent of graft infection are usually nonspecific, and their detection by radiographic methods, such as computed tomography (CT), magnetic resonance imaging (MRI), and leukocyte -imaging, can be difficult. The purpose of this study was to evaluate the predictive value (PV) of indium-111-labeled white blood cell scanning (WBCS) and MRI in patients who were suspected of having intracavitary vascular graft infection (IGF). The study was done as a cross-control retrospective, single-center study. Fifty-eight In-111-labeled WBC scans and 59 MRIs were performed in suspected patients between January 1995 and January 2005. Among the 40 suspected patients, 35 cases of aorta graft infection were identified intraoperatively. The diagnosis of IGF was based on clinical signs, microbiological and histological examination, MRI and leukocyte imaging, and lack of graft incorporation with surrounding fluid observed intraoperatively. The positive PV (PPV) of MRI was 95% (95% confidence interval [CI] 84-105%) compared to In-111-labeled WBCS, which was 80% (95% CI 62-96%). The negative PV (NPV) of MRI was 80% (95% CI 68-92%) compared to 82% (95% CI 69-94%) for In-111-labeled WBCS. MRI showed a nonsignificant but better PPV for detecting IGF compared to In-111 leukocyte imaging. The NPVs for MRI and In-111-labeled WBCS were very near each other, with a very small advantage for In-111-WBCS. This comparison study suggested MRI as a primary diagnostic modality to investigate patients suspected of having aortic graft infections before In-111-labeled WBCS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823040     DOI: 10.1016/j.avsg.2007.03.018

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  7 in total

1.  Prosthetic vascular graft infections: a contemporary approach to diagnosis and management.

Authors:  Avish Nagpal; Muhammad R Sohail
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

Review 2.  How To Diagnose and Manage Infected Endografts after Endovascular Aneurysm Repair.

Authors:  Carlo Setacci; Emiliano Chisci; Francesco Setacci; Leonardo Ercolini; Gianmarco de Donato; Nicola Troisi; Giuseppe Galzerano; Stefano Michelagnoli
Journal:  Aorta (Stamford)       Date:  2014-12-01

3.  Diagnosis of Graft Infection Using FDG PET-CT.

Authors:  Hunbo Shim; Kiick Sung; Wook Sung Kim; Young Tak Lee; Pyo Won Park; Dong Seop Jeong
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2012-06-07

4.  Clinical utility of indium 111-labeled white blood cell scintigraphy for evaluation of suspected infection.

Authors:  Sarah S Lewis; Gary M Cox; Jason E Stout
Journal:  Open Forum Infect Dis       Date:  2014-09-17       Impact factor: 3.835

Review 5.  Cross-sectional imaging of aortic infections.

Authors:  D J Murphy; A R Keraliya; M D Agrawal; A Aghayev; M L Steigner
Journal:  Insights Imaging       Date:  2016-10-19

Review 6.  Femoral Vein Reconstruction for Aortic Infections.

Authors:  Zachary S Pallister; Jayer Chung
Journal:  Vasc Specialist Int       Date:  2021-03-31

7.  Evidence-based guideline of the European Association of Nuclear Medicine (EANM) on imaging infection in vascular grafts.

Authors:  Chiara Lauri; Alberto Signore; Andor W J M Glaudemans; Giorgio Treglia; Olivier Gheysens; Riemer H J A Slart; Roberto Iezzi; Niek H J Prakken; Eike Sebastian Debus; Susanne Honig; Anne Lejay; Nabil Chakfé
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-04-04       Impact factor: 10.057

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.